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Abstract
Aims Weinvestigated theassociationbetweenalcohol consumptionanddiabetic retinopathyanddeteriorationofvisualacuity
in individuals with Type 2 diabetes.
Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55–81 years enrolled in the
AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled
Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report.
Moderate and heavy alcohol consumption was defined as 1–14 and > 14 drinks ⁄week, respectively. Diabetic retinopathy,
measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early
Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of
visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using
a Snellen chart.
Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640
participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current
moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of
diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR
1.83; 95% CI 1.34–2.48; P < 0.001).
Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy
in individuals with Type 2 diabetes.
Diabet. Med. 27, 1130–1137 (2010)
Keywords alcohol consumption, diabetic retinopathy, visual acuity
Abbreviations ADVANCE, Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled
Evaluation Trial; AdRem, ADVANCE Retinal Measurement Study; ETDRS, Early Treatment of Diabetic Retinopathy
Study; logMAR, logarithm of the minimum angle of resolution
Introduction
Retinopathy is a serious microvascular complication of diabetes
mellitus. Diabetic maculopathy can cause loss of vision. Lifestyle
factors, including alcohol consumption, may alter the risk of
retinopathy or visual loss in individuals with diabetes. One of the
proposed pathological mechanisms for diabetic retinopathy is
inflammation [1]. Moderate alcohol consumption, as compared
with no or occasional consumption, has been associated with
lower concentrations of C-reactive protein and improved
glycaemia through increased insulin sensitivity [2,3]. However,
alcohol is toxic to neurological tissues, including the retina, and
heavy consumption may induce oxidative stress in these tissues
and impair vision [4].
Correspondence to: Joline W. J. Beulens, Julius Centre for Health Sciences
and Primary Care, University Medical Centre Utrecht, Room STR. 7.133, PO
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Limited epidemiological evidence for the association between
alcohol consumption and diabetic eye disease exists. Previous
studies on alcohol consumption anddiabetic retinopathy showed
differing results [5–9]. However, these studies were limited by
either cross-sectional designs or small sample sizes. No prior
study has examined the association between alcohol
consumption and deterioration of visual acuity in individuals
with diabetes.
In this study, we explore the hypothesis that alcohol
consumption is associated with the incidence and progression
of diabetic retinopathy and the deterioration of visual acuity
among individuals with Type 2 diabetes in the Action in Diabetes
and Vascular Disease: Preterax and Diamicron MR Controlled
Evaluation (ADVANCE) Retinal Measurement (AdRem) study.
The main results of the AdRem study have been reported [10].
Research designs and methods
Study population
The study population consisted of participants included in the
AdRem study. AdRem, a sub-study of the ADVANCE trial, is a
randomized controlled trial of blood pressure lowering and
intensive glucose controlamong individuals with Type 2 diabetes
from 39 centres in 14 countries from Asia, Australia, Europe and
North America with access to retinal cameras. Ethics approval
was obtained from the institutional review board of each centre.
All participants provided written informed consent [10].
Participants eligible for the ADVANCE trial were diagnosed
with Type 2 diabetes at age 30 or older, were aged 55 or older
at entry and were at high risk of vascular disease, as defined
by either a diagnosis of diabetes of 10 years or more at entry, or
age 65 or older at entry, or a history of cardiovascular disease or
other complications of diabetes, or having at least one of a
number of other risk factors for vascular disease [11]. Exclusion
criteria for theAdRemstudy includedpreviousophthalmological
interventions in either one or both eyes, which might interfere
with retinal circulation, or the presence of severe cataracts or
pupils unable to dilate to 4 mm, which prevented quality
stereoscopic photographs [11]. Details of the study population
have been described [11,12].
Measurement of anthropometry, blood pressure and
biochemical variables were performed. Information on
ethnicity, duration of diabetes, exercise, cigarette smoking,
medications and family history of diabetes were collected in the
baseline questionnaire. Ethnicity was classified as Caucasian ⁄
European, Chinese, South Asian ⁄South-East Asian and ‘others’,
which included mainly individuals of Arab, African or mixed
ethnicity [11].
Measurement of alcohol consumption
Current and past alcohol consumption was measured by self
report in the baseline questionnaire. Participants reported the
number of standard drinks of wine, beer or spirits consumed per
week on averagecurrently and in the past, prior to their diagnosis
of diabetes. For example, if the standard size of spirit was 1.5 oz
(45 ml) and if a participant consumed a 6-oz (180 ml) glass, he
would have reported four standard drinks. The question on
alcohol intake was phrased to report the standardized size of
consumption for each country. In this study, we assumed that a
standard drink had the same size across study centres. Alcohol
consumption was categorized into moderate intake (1–
14 drinks ⁄week) and heavy intake (>14 drinks ⁄week) using
0 drinks per week as the reference category. In a sensitivity
analysis, we re-categorized alcohol consumption into low intake
(1–7 drinks ⁄week), moderate intake (8–14 drinks ⁄week) and
heavy (>14 drinks ⁄week). Participants were also asked whether
they had decreased alcohol intake because of their health. In
additional to ethnicity, we adjusted for study centre to account
for the variation of serving size and strength of alcohol between
countries.
Retinal photography and testing for visual acuity
Stereoscopic photographs were taken with 35-mm high-quality
colour film (Kodak EPR64 135-36) of both eyes according to the
seven-field Early Treatment of Diabetic Retinopathy Study
(ETDRS) protocol at baseline, biennial follow-up and final
visits. The seven fields include one centred on the optic disc,
one centred on the macula, one temporal to the macula, two
superior and two inferior fields. In the AdRem study, diabetic
lesions were graded in each field by comparing them with the
ETDRS standard photographs according to the modified ETDRS
classification [13]. The diabetic lesions were used to define the
endpoint of 2-step progression on the ETDRS scale. Vascular
lesions were graded in each field according to the Atherosclerosis
Risk in Communities Study protocol [14]. Retinal photographs
were graded centrally in the AdRem Sub-study Coordination
Centre at the University Medical Centre Utrecht, the
Netherlands.
Trained researchers tested visual acuity as a part of clinical
assessment at baseline and at the final visits following a
standardized protocol. Best corrected visual acuity was
measured in both eyes (corrected by glasses or contact lens, or
through a pinhole) using a Snellen chart at a distance of 6 metres.
Participants covered the eye not being tested. The best score for
visual acuity was recorded for each eye using metric notation
from the Snellen chart, where the numerator was ‘6 metres’ [15].
The denominators were based on the Snellen metric notation.
Table 1 shows the conversion of the Snellen metric notation to
imperial and decimal notations. Visual impairment at baseline
was defined as a best-corrected visual acuity of less than 6 ⁄6 in
the Snellen metric notation or equivalent.
Definition of outcomes
Outcomes of diabetic retinopathy were defined as either a 2-step
progression of diabetic lesions in the modified ETDRS score
based on the worst eye or the presence of any retinal vascular
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lesions at the final visits, including arteriovenous nicking,
microaneurysms, retinal haemorrhages, cotton-wool spots,
hard exudates and macular oedema These retinal vascular
lesions were either presented at baseline or developed between
baseline and final visits. Deterioration of visual acuity was
defined as a decrease of two lines or more from the Snellen metric
notation (or equivalent in imperial or decimal notations;
Table 1) in best vision in either or both eyes between the
baseline and the final visits.
Statistical analyses
Characteristics at baseline, including means and standard
deviations for continuous variables and percentages for
categorical variables, were described. We used analysis of
variance and v2-tests to test whether continuous and categorical
variables differed across level of alcohol consumption. We
used multivariable logistic regression analyses to explore the
association between current and past alcohol consumption
and outcomes of diabetic retinopathy and deterioration in
visual acuity. Odds ratios, using 0 drinks ⁄week as the reference
category, were used to estimate relative risk and were
presented with 95% confidence intervals. In the base model, we
adjusted for interventions for treatment of blood glucose and
bloodpressure.We includedcovariates inmultivariablemodels if
they wereofapriori clinical relevance or if inclusion substantially
influenced the observed odds ratios. Potential confounders
included age, sex, cigarette smoking, BMI, HbA1c, systolic
blood pressure, duration of diabetes and ethnicity. We reported
theP-value for a linear trend across level of alcohol consumption.
Ina sensitivityanalysis,wealsomodelledalcohol consumption
as a continuous variable. We stratified the analyses by ethnic
groups (Caucasians vs. non-Caucasians) and tested whether the
associations between alcohol consumption and diabetic
retinopathy or deterioration of visual acuity differed by ethnic
groups using the v2-test. We repeated the multivariable analyses
after excluding participants who were heavy drinkers in the past
but currently abstained from alcohol. For analysis specific for a
given type of alcoholic beverage, for example, beer or wine, we
also adjusted for consumption of other types of beverage in the
fully adjusted models. To assess whether the association of
alcohol differed with cigarette smoking, we included an
interaction term between smoker vs. non-smokers and level of
alcohol consumption. To assess if the presence of cataract,
macular oedema or visual impairment at baseline account for the
association between alcohol consumption and deterioration of
visual acuity, we additionally adjusted for these covariates in the
multivariable-adjusted analyses. Statistical analyses were
performed using STATA 9.0 (Stata Corporation, College
Station, TX, USA).
Results
After excluding two participants with missing data on
consumption of alcohol at baseline, these analyses included
1239 participants with retinal photographs from baseline and
final visits and with data on deterioration of visual acuity.
Characteristics at baseline of the study population by level of
current alcohol consumption are shown in Table 2. The
average age of participants was 65 years. Alcohol drinkers
had higher values for BMI, waist–hip ratio and systolic blood
pressure, but a lower level of HbA1c than those who drank no
alcohol. Participants who consumed alcohol were more likely
to smoke and to be physically inactive. Moderate drinkers
had lower prevalence of retinopathy and visual impairment
and shorter duration of diabetes at baseline, as compared
with non-drinkers or heavy drinkers. Substantial ethnic
differences existed in the pattern of alcohol consumption. A
higher proportion of Caucasians acknowledged drinking
alcohol than Chinese or South Asians. The characteristics at
baseline did not differ between participants who consumed
alcohol in the past and those consumed currently (data not
shown).
After a mean follow-up of 5.5 years, of 1239 participants we
identified 182 participants with a 2-step progression in the
ETDRS score, 640 participants with the presence of any retinal
vascular lesions and 693 participants with a deterioration of
visual acuity. We observed no associations between current
alcohol consumption and the 2-step progression of ETDRS score
Table 1 Conversion for the measurement of visual acuity in the AdRem
Study
Snellen notation (metric) Snellen notation (imperial) Decimal
6 ⁄ 6000 20 ⁄ 20000 0.001
6 ⁄ 600* 20 ⁄ 2000 0.01
6 ⁄ 120 20 ⁄ 400 0.05
6 ⁄ 90 20 ⁄ 300 0.07
6 ⁄ 75 20 ⁄ 250 0.08
6 ⁄ 60 20 ⁄ 200 0.10
6 ⁄ 52.5 20 ⁄ 175 0.11
6 ⁄ 50 20 ⁄ 160 0.12
6 ⁄ 45 20 ⁄ 150 0.13
6 ⁄ 37.5 20 ⁄ 125 0.16
6 ⁄ 36 20 ⁄ 120 0.17
6 ⁄ 30 20 ⁄ 100 0.20
6 ⁄ 24 20 ⁄ 80 0.25
6 ⁄ 21 20 ⁄ 70 0.29
6 ⁄ 18 20 ⁄ 60 0.33
6 ⁄ 15 20 ⁄ 50 0.40
6 ⁄ 12 20 ⁄ 40 0.50
6 ⁄ 9 20 ⁄ 30 0.67
6 ⁄ 8.5 20 ⁄ 28 0.71
6 ⁄ 7.5 20 ⁄ 25 0.80
6 ⁄ 6.7 20 ⁄ 22 0.90
6 ⁄ 6 20 ⁄ 20 1.00
6 ⁄ 5 20 ⁄ 16 1.20
6 ⁄ 4.5 20 ⁄ 15 1.33
6 ⁄ 4 20 ⁄ 13 1.50
6 ⁄ 3 20 ⁄ 10 2.00
*Count fingers at 2 feet (0.6 metres).
Hand motion at 2 feet (0.6 metres).
World Health Organization’s definition of blindness.
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in either unadjusted or multivariable-adjusted logistic regression
models. Logistic regression analysis adjusted for age and sex
showed a protective association (P for trend = 0.02) of current
consumption of alcohol on the presence of any retinal vascular
lesions at follow-up, comparing 1–14 drinks ⁄week (odds ratio
0.65, 95% confidence interval 0.49–0.85) with no consumption.
After adjusting for potential confounders, the association was no
longer statistically significant. Ethnicity confounded and
strengthened the association between alcohol and diabetic
retinopathy or deterioration of visual acuity (Table 3).
For visual acuity, we observed an association between current
alcohol consumption and the deterioration of visual acuity at
follow-up in the age- and sex-adjusted regression model,
comparing moderate and heavy consumption with no
consumption (P for trend < 0.001). After adjusting for
potential confounders, the association strengthened to an odds
ratio of 1.83 (95% confidence interval 1.34–2.48) for 1–14
drinks ⁄week and of 2.09 (95% confidence interval 1.28–3.40)
for >14 drinks ⁄week (Table 3). Similar significant results for the
same comparisons were observed for past alcohol consumption
(odds ratio 1.60, 95% confidence interval 1.17–2.19 for
1–14 drinks ⁄week and odds ratio 2.16, 95% confidence
interval 1.46–3.20 for >14 drinks ⁄week; P < 0.001). When
modelling alcohol consumption as a continuous variable, we
observed a 2% increase in the risk of deterioration of visual
acuity for each additional alcoholic drink consumed per week
(multivariable-adjusted odds ratio 1.02; 95%confidence interval
1.00–1.04, P = 0.01).
As ethnicity confounded the association between alcohol and
diabetic retinopathy and deterioration of visual acuity, we
stratified the multivariable regression analyses by ethnic groups
(Caucasians vs. non-Caucasians). For progression of retinopathy
Table 2 Baseline characteristics by levels of current alcohol consumption (n = 1239)
Current alcohol consumption
Drinks ⁄ week 0 1–14 >14
Number (%) 833 (67.2) 316 (25.5) 90 (7.3)
Alcohol consumption (drinks ⁄ week)
Wine 0 1.7  2.8 4.6  8.1*
Spirits 0 1.3  2.7 9.8  13.3*
Beer 0 2.5  3.1 13.3  16.7*
Age (years) 65.0  5.5 65.1  6.0 65.5  5.01
Sex—male (%) 49.7 79.8 95.6*
Ethnicity (%)
Caucasian 30.3 73.7 76.7*
Chinese 54.9 14.9 20.0
South Asian 12.7 7.3 2.2
Others 2.2 4.1 1.1
Duration of diabetes (years) 7.5  6.2 6.4  5.4 7.1  6.3*
Current smoker (%) 13.0 17.1 22.2*
Exercise (%) 33.6 24.7 25.6*
Parental history of diabetes (%)
1 parent 23.7 29.4 27.8
2 parents 2.8 1.9 4.4
Baseline retinopathy (%) 41.8 29.8 37.8*
Baseline visual impairment (%) 66.2 51.3 58.9*
BMI (kg ⁄ m2) 27.3  4.8 28.4  4.4 28.7  5.3*
Waist–hip ratio 0.92  0.07 0.95  0.07 0.98  0.06*
HbA1c (%) 7.2  1.3 6.8  1.0 6.8  1.2*
Glucose (mmol ⁄ l) 8.5  3.0 8.3  2.1 8.6  2.6
Triglyceride (mmol ⁄ l) 2.0  1.3 1.9  1.1 1.9  1.1
LDL cholesterol (mmol ⁄ l) 3.1  0.9 3.1  0.9 2.9  0.8
Total cholesterol (mmol ⁄ l) 5.2  1.1 5.2  1.1 5.0  1.0
HDL cholesterol (mmol ⁄ l) 1.2  0.3 1.2  0.3 1.3  0.4
Systolic blood pressure (mmHg) 134  20.1 137  21.5 138  19.2*
Diastolic blood pressure (mmHg) 76.0  10.2 79.4  10.6 78.8  10.0*
Insulin use (%) 0.96 0.95 0
Blood pressure medication use (%) 71.5 66.5 68.9
Oral hypoglycaemic agent use (%) 91.4 79.8 90.0*
Participants allocated into treatment for blood pressure (%) 50.5 49.1 48.9
Participants allocated into treatment for intensive glucose control (%) 52.1 48.7 44.4
Data are mean  standard deviation, unless otherwise indicated.
*P < 0.05.
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and deterioration of visual acuity, the odds ratios for moderate
drinking (1–14 drinks ⁄week) were lower among Caucasians
than non-Caucasians, but these differences were not statistically
significant (Table 4).
For analyses of specific alcoholic beverages, current moderate
consumption of each of wine, beer or spirits were all associated
with deterioration of visual acuity at follow-up, as compared
with no current consumption of each type of the alcoholic
beverages. The magnitude of association was stronger with an
increased amount of consumption of beer or spirits, in
comparison with wine (Table 5). None of the specific alcoholic
beverages were associated with the progression of retinopathy or
presence of retinal vascular lesions. We observed similar results
when we repeated the beverage-specific analyses using past
consumption of each type of alcoholic beverages as exposures
(data not shown).
In sensitivity analyses, when including study centre, diastolic
blood pressure, exercise, retinopathy and visual impairment at
baseline, the presence of cataract or macular oedema in the
regression models, we observed minimal change in the




0 1–14 >14 P-value*
2-steps change in ETDRS score
Cases 133 ⁄ 833 42 ⁄ 316 12 ⁄ 90
Model 1 1.0 0.81 (0.55, 1.19) 0.82 (0.42, 1.57) 0.3
Model 2 1.0 0.94 (0.63, 1.41) 0.92 (0.47, 1.80) 0.7
Model 3 1.0 1.08 (0.70, 1.67) 1.07 (0.54, 2.13) 0.8
Any retinal vascular lesion
Cases 456 ⁄ 833 139 ⁄ 316 45 ⁄ 90
Model 1 1.0 0.65 (0.49, 0.85) 0.83 (0.53, 1.30) 0.02
Model 2 1.0 0.73 (0.55, 0.97) 0.91 (0.57, 1.46) 0.1
Model 3 1.0 0.88 (0.65, 1.20) 1.08 (0.66, 1.75) 0.9
Deterioration of visual acuity
Cases 435 ⁄ 833 200 ⁄ 316 58 ⁄ 90
Model 1 1.0 1.70 (1.29, 2.25) 1.86 (1.16, 2.96) <0.001
Model 2 1.0 1.76 (1.33, 2.34) 1.93 (1.20, 3.10) <0.001
Model 3 1.0 1.83 (1.34, 2.48) 2.09 (1.28, 3.40) <0.001
The base model is adjusted for treatment interventions for blood glucose and blood pressure.
Model 1: age, sex-adjusted.
Model 2: model 1 + HbA1c, systolic blood pressure, duration of diabetes, BMI, cigarette smoking.
Model 3: model 2 + ethnicity.
*P-value is for a linear trend across levels of alcohol consumption.
ETDRS, Early Treatment of Diabetic Retinopathy Study.
Table 4 Estimated odds ratios (95% confidence intervals) on the association between alcohol consumption and diabetic retinopathy and deterioration
of visual acuity, stratified by ethnicity
1–14 drinks ⁄ week
Pethnic dierenceCaucasian Non-Caucasian
2-steps change in ETDRS score 0.84 (0.46, 1.55) 1.50 (0.82, 2.76) 0.2
Any retinal vascular lesions 0.91 (0.62, 1.35) 0.75 (0.45, 1.25) 0.6
Deterioration of visual acuity 1.63 (1.10, 2.41) 2.61 (1.54, 4.44) 0.2
>14 drinks ⁄ week
Caucasian Non-Caucasian Pethnic dierence
2 steps change in ETDRS score 1.06 (0.43, 2.57) 1.27 (0.40, 4.08) 0.8
Any retinal vascular lesions 0.99 (0.55, 1.76) 1.73 (0.45, 4.60) 0.4
Deterioration of visual acuity 2.11 (1.17, 3.82) 1.71 (0.68, 4.29) 0.7
Multivariable regression models adjusted for blood pressure treatment intervention, blood glucose treatment intervention, age, sex,
HbA1c, systolic blood pressure, duration of diabetes, BMI and cigarette smoking.
ETDRS, Early Treatment of Diabetic Retinopathy Study.
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magnitude of the associations between alcohol and diabetic
retinopathy or deterioration of visual acuity. Excluding the
participants who drank heavily in the past and had given up
alcohol for reasons of ill health did not change our results
materially. We observed similar results when we re-categorized
alcohol consumption into none (0 drinks ⁄week), low
(1–7 drinks ⁄week), moderate (8–14 drinks ⁄week) and heavy
(>14 drinks ⁄week). In addition, we did not find an interaction
between alcohol consumption and cigarette smoking (P = 0.4).
Discussion
In this multi-centre study of individuals with Type 2 diabetes,
alcohol consumption was not associated with retinopathy as
defined by a 2-step progression in the ETDRS score or the
presence of any retinal vascular lesions at follow-up. However,
those who consumed alcohol were more likely to have
experienced a decline in their visual acuity at follow-up when
compared with those who abstained from alcohol. The
magnitude of this association increased with increasing
amounts of alcohol consumed and was unchanged after
adjusting for potential confounders.
Our results for retinopathy are consistent with a previous
cohort study of patients with either Type 1 or Type 2 diabetes [5].
In the Casteldaccia Eye Study, daily consumption of alcohol for
20 years or more, as compared with no consumption, was
inversely associated with diabetic retinopathy in unadjusted, but
not in multivariate-adjusted, analyses [7]. Similarly, in theBeijing
Eye study, diabetic participants who consumed alcohol of any
amount, as compared with those who did not consume alcohol,
was associated with a lower risk of retinopathy in unadjusted
analysis, but the association attenuated after adjusting for
potential confounders [9]. By contrast, the EURODIAB
Prospective Complications Study of Type 1 diabetes showed a
reduced risk of retinopathy with moderate alcohol consumption
in multivariable-adjusted analyses [6]. Although we did not
observe an overall protective association of moderate alcohol
consumptionondiabetic retinopathy, weobserved inCaucasians
a non-significant inverse association between moderate alcohol
consumption and progression of retinopathy and presence of
retinal vascular lesions.
This study showed that both moderate and heavy alcohol
consumption were associated with a decline in visual acuity in a
population with Type 2 diabetes. The relationship with the
decline in visual acuity was continuous through the distribution
ofalcohol consumption.Anadditional alcoholicdrinkconsumed
per week was associated with a 2% increase in risk of decline in
visual acuity. To our knowledge, no previous study has shown
this association. In a meta-analysis of observational studies,
heavy consumption of alcohol, defined as more than three
standard drinks per day, was associated with an increased risk of
early age-related macular degeneration in the general population
[16], the leading cause of blindness in developed countries
[17,18]. Large population-based prospective studies on the
associationbetweenalcohol consumptionand the riskof cataract
showed differing results, from no association [19–21] to an
increased risk [22].
Why consumption of alcohol was associated with a decline in
visual acuity in Type 2 diabetes was unclear. Alcohol is known
for its neurotoxic properties, which could induce oxidative
damage to the retinaand theopticnerve, leading tovisual loss [4].
We observed that the size of association for deteriorating vision
appeared to be stronger for beer and spirits than for wine. The
natural antioxidants in wine may partially offset the adverse
effects of alcohol [23]. Alcohol provides energy with little
nutritive value and dietary intake of essential micronutrients,
Table 5 Estimated odds ratios (95% confidence intervals) on the association between types of alcoholic beverages and diabetic retinopathy and





2 steps change in ETDRS score 1.0 1.00 (0.58, 1.72) — 0.6
Any retinal vascular lesion 1.0 0.80 (0.55, 1.15) 0.61 (0.16, 2.30) 0.1
Deterioration of visual acuity 1.0 1.63 (1.12, 2.37) 0.94 (0.25, 3.47) 0.03
Beer consumption
2 steps change in ETDRS score 1.0 0.96 (0.56, 1.64) 0.97 (0.36, 2.67) 0.9
Any retinal vascular lesion 1.0 0.83 (0.58, 1.19) 1.38 (0.69, 2.77) 1.0
Deterioration of visual acuity 1.0 1.62 (1.12, 2.33) 2.47 (1.17, 5.18) 0.01
Spirits consumption
2 steps change in ETDRS score 1.0 0.95 (0.53, 1.73) 2.14 (0.85, 5.36) 0.3
Any retinal vascular lesion 1.0 1.08 (0.72, 1.62) 1.26 (0.56, 2.81) 0.5
Deterioration of visual acuity 1.0 1.44 (0.95, 2.18) 1.95 (0.86, 4.45) 0.03
Multivariable regression models adjusted for blood pressure treatment intervention, blood glucose treatment intervention, age, sex,
HbA1c, systolic blood pressure, duration of diabetes, BMI, cigarette smoking, ethnicity and other types of alcoholic beverage.
*P-value is for a linear trend across levels of alcohol consumption.
ETDRS, Early Treatment of Diabetic Retinopathy Study.
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including B vitamins and vitamin A, decreases with the
increasing amount of alcohol consumed [24]. In addition,
chronic consumption of alcohol alters the metabolism of
vitamin A, depletes levels of hepatic vitamin A and causes
visual loss [25].
Alternatively, the association between alcohol consumption
and decline of visual acuity could be because of confounding
effects. We demonstrated that our results were independent of
the presence of cataract or macular oedema. It is possible that
individuals who consume alcohol have different lifestyle
characteristics that increase the risk of visual loss. Adjustment
of cigarette smoking did not alter the association observed.
However, residual confoundingofunmeasuredbehaviours could
not be ruled out. We had no information on social class. If
participants in lower social classes both drank more alcohol and
were less able to afford glasses with prescription, this would
overestimate the reported association between alcohol
consumption and the decline of visual acuity as visual
measurement was performed corrected by glasses or contact
lens, or through a pinhole. Nevertheless, we observed similar
results when adjusting for factors associated with social class,
such as BMI [26], smoking and exercise [27].
A strength of this study relates to its robust ascertainment of
retinopathy, using mydriatic seven-field stereoscopic
photography of both eyes, thereby reducing misclassification
of endpoints. Another strength is its prospective design. In
addition, the multi-centred design of the study allows the
investigation of the ethnic differences in the patterns of alcohol
consumption. Our study has potential limitations. Because of a
limited number of cases of retinopathy, we may not have
enough statistical power to detect associations with small effect
sizes. The power further diminished when we stratified the
analyses by ethnicity. Consumption of alcohol was measured by
self report. Participants were asked to report the average
number of standard drinks they consumed per week. The
interpretation of ‘a standard drink’ may vary between
participants. Any random measurement errors would
attenuate the associations observed. However, individuals
with strong social desirability may under-report their alcohol
intake [28] and such systematic difference in reporting would
bias the results in either direction. At present, there is no valid
biomarker to measure alcohol consumption objectively. This
study included specific questions on the frequency, the amount
and the type of alcohol consumed, which has been shown to
improve validity of the exposure measurement [29]. We do not
have information on the strength and serving size of alcohol by
country. However, adjusting for ethnicity and study centre did
not alter our results.
Measuring visual acuity requires cooperation and adequate
cognitive function of an individual to participate. Heavy
consumption of alcohol can impair cognitive function [30].
Therefore, differential misclassification of outcomes (visual
acuity) could have been present, which could over- or
underestimate the true association. Of the various charts
available to measure visual acuity, the Snellen chart is the one
most commonly used in clinical settings. Although the Snellen
notation is universally understood, the non-linear and non-
geometric relationships of the sizes of the letters between
successive lines could make it difficult to assess change over
time [31]. Any random measurement errors would have
attenuated the association observed. Alternatively, the
logarithm of the minimum angle of resolution (logMAR) chart,
with equal linear steps between lines, facilitates the analysis of
change in visual acuity more effectively [32]. With respect to the
reproducibility of visual score, a comparison of the ETDRS
logMAR chart, the compact reduced logMAR chart and the
Snellen chart indicated that these charts yield comparable results
with similar test–retest variability [33].Given the largenumberof
study centres in different countries involved, to ensure that
measuring and scoring visual acuity were consistent across study
centres, the simple scoring system and the reduced testing time
made the use of the Snellen chart and its notation preferable in
this study.
In conclusion, these analyses of the AdRem study show that
alcohol consumption is associated with an increased risk of
deterioration of visual acuity, but not with progression of
retinopathy in a population with Type 2 diabetes. We support
further studies to confirm these findings.
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